feed,title,long_url,short_url
Benzinga,Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer,https://www.benzinga.com/pressreleases/20/10/g18041294/galera-therapeutics-announces-positive-interim-data-from-first-cohort-of-patients-in-pilot-phase-1,https://j.mp/35wPSXv
